Today: 7 February 2026
Subscribe
Browse Category

NYSE:SLB News 11 January 2026 - 7 February 2026

Oil stock prices in focus: Exxon, Chevron earnings land as crude holds near highs ahead of OPEC+

Oil stock prices in focus: Exxon, Chevron earnings land as crude holds near highs ahead of OPEC+

Brent crude closed at $70.69 a barrel Friday, with U.S. West Texas Intermediate at $65.21, as traders eyed rising U.S.-Iran tensions and new Iran-related sanctions. Exxon Mobil posted adjusted Q4 earnings of $1.71 per share and Chevron reported $1.52, both beating estimates. A Reuters poll forecasts weaker oil prices in 2026 despite current strength, with Brent averaging $62.02 a barrel.
31 January 2026
·······
SLB stock price today: Shares dip as Oman contract win meets oil-market nerves

SLB stock price today: Shares dip as Oman contract win meets oil-market nerves

SLB shares fell 0.3% to $48.30 Friday afternoon, extending earlier losses and trading below their January peak. The company announced two five-year equipment contracts in Oman’s Block-6, while traders watched oil prices and awaited U.S. drilling data. About 10.8 million shares changed hands. OPEC+ is expected to keep output steady at its meeting Sunday, according to delegates.
30 January 2026
···
SLB stock price today: Venezuela repair talks lift shares as OPEC+ meeting nears

SLB stock price today: Venezuela repair talks lift shares as OPEC+ meeting nears

SLB rose 1.4% to $49.86 by midday Monday after reports of U.S. talks to boost Venezuelan oil output, potentially involving SLB and rivals. Halliburton and Baker Hughes also gained. SLB forecast a weaker Q1, with adjusted core profit expected to drop up to 20%. Oil prices eased after last week’s storm-driven surge.
26 January 2026
·······
Energy stocks close at fresh records as oil jumps on Iran fears; what to watch this week

Energy stocks close at fresh records as oil jumps on Iran fears; what to watch this week

The S&P 500 energy index closed at a record high Friday, up 0.6%, as oil prices jumped nearly 3% after new U.S. sanctions on Iranian exports and supply concerns. Brent settled at $65.88 a barrel, U.S. crude at $61.07. Chevron’s Tengiz oilfield in Kazakhstan remains shut after a fire. Exxon Mobil rose 1% to $134.97; Occidental gained 2.2% to $44.10.
25 January 2026
····
Oil stocks face Monday test after crude hits 1-week high on Iran risk, with Big Oil earnings ahead

Oil stocks face Monday test after crude hits 1-week high on Iran risk, with Big Oil earnings ahead

Brent settled at $65.88 and U.S. WTI at $61.07 on Friday, both up nearly 3% amid renewed U.S.-Iran supply concerns. Exxon Mobil rose 1%, ConocoPhillips 1.5%, while Chevron was flat. A Trafigura-chartered tanker left Venezuela for the U.S. with 1 million barrels under a new supply deal. Baker Hughes reported the U.S. rig count at 544, down 32 from a year ago.
25 January 2026
·····
SLB stock price in focus: Venezuela ramp-up talk meets softer Q1 signals

SLB stock price in focus: Venezuela ramp-up talk meets softer Q1 signals

SLB shares closed down 0.3% at $49.15 after its earnings report Friday. CEO Olivier Le Peuch said customers are inquiring about Venezuela, but licenses and payment terms remain unresolved. The company posted Q4 revenue of $9.75 billion and raised its dividend 3.5% to $0.295 per share. U.S. officials have reportedly discussed deploying SLB and others to restore Venezuela’s oilfields.
25 January 2026
···
SLB stock price swings after earnings beat: $4B return plan and Venezuela ramp in focus

SLB stock price swings after earnings beat: $4B return plan and Venezuela ramp in focus

SLB shares fell 0.3% to $49.15 after the company topped quarterly profit estimates and raised its dividend by 3.5%. Management warned of a weaker first quarter and said it could quickly expand in Venezuela if licensing and payments are secured. Fourth-quarter revenue reached $9.75 billion, with free cash flow at $2.29 billion. SLB expects 2026 revenue between $36.9 billion and $37.7 billion.
24 January 2026
···
SLB stock price swings after earnings beat, dividend hike and Venezuela signals

SLB stock price swings after earnings beat, dividend hike and Venezuela signals

SLB reported Q4 adjusted earnings of 78 cents per share, beating forecasts, and raised its dividend by 3.5% to $0.295. Shares rose 0.3% to $49.47 after early gains faded. The company set 2026 revenue guidance up to $37.7 billion and plans to return over $4 billion to shareholders. CEO Olivier Le Peuch cited rising customer interest in Venezuela but said expansion depends on licenses and payment terms.
23 January 2026
···
SLB stock price swings after earnings beat as $4 billion return plan meets Venezuela questions

SLB stock price swings after earnings beat as $4 billion return plan meets Venezuela questions

SLB shares closed nearly unchanged at $49.33 Friday after beating quarterly profit forecasts and raising its dividend, but warned of weaker first-quarter results. North America revenue jumped 26%. Executives said SLB is ready to expand in Venezuela if U.S. licensing and payment terms are resolved. Trading volume was high as investors weighed the earnings beat against a cautious outlook.
23 January 2026
···
Oil stocks brace for Tuesday as Brent holds near $64 and tariff jitters cloud demand

Oil stocks brace for Tuesday as Brent holds near $64 and tariff jitters cloud demand

Brent crude edged up to $64.14 a barrel Tuesday as oil stocks reopened after the U.S. holiday, with traders watching tensions over Greenland and new U.S. tariff threats on Europe. Exxon Mobil gained 0.6% to $129.89, while Chevron held at $166.26. S&P 500 and Nasdaq futures fell over 1.2%. The Energy Information Administration’s weekly oil report is due Thursday.
19 January 2026
·······
Oil stocks brace for holiday week as Chevron Venezuela license and $60 oil collide

Oil stocks brace for holiday week as Chevron Venezuela license and $60 oil collide

Chevron is set to gain expanded rights in Venezuela, allowing cash payments to the government and full crude sales, U.S. Energy Secretary Chris Wright said Friday. Brent crude closed at $64.13 a barrel, up 0.6%, while Chevron shares ended nearly flat at $166.26. The U.S. dismissed reports of using Venezuelan oil to refill the Strategic Petroleum Reserve. North American rig count rose by 28 to 769, with U.S. rigs down by one.
18 January 2026
········
SLB stock closes at fresh 52-week high as Venezuela oil push keeps traders circling

SLB stock closes at fresh 52-week high as Venezuela oil push keeps traders circling

SLB shares rose 2.3% to $46.97, hitting a 52-week high on heavy volume as oilfield-services stocks outperformed a weaker S&P 500. Investors tracked U.S. policy moves on Venezuela, with Chevron expected to receive an expanded license for Venezuelan oil. SLB’s earnings report is set for January 23. Physical prices for Venezuelan crude narrowed against Brent, signaling changing market flows.
15 January 2026
···
Oil stocks brace for Monday as Bessent hints Venezuela sanctions relief; Chevron, Exxon in focus

Oil stocks brace for Monday as Bessent hints Venezuela sanctions relief; Chevron, Exxon in focus

U.S. Treasury Secretary Scott Bessent said sanctions on Venezuela could be eased as soon as next week to boost oil exports, with proceeds possibly flowing back into the country. Brent crude closed Friday at $63.34 a barrel, WTI at $59.12, amid ongoing tensions in Iran and Ukraine. President Trump signed an order blocking seizure of Venezuelan oil revenue in U.S. accounts. Chevron and Exxon shares rose; ConocoPhillips slipped.
11 January 2026
·······
1 2

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop